NTRK1 and cancer: Because it has been reported that patients with metastatic or recurrent solid tumors possessing NTRK fusion genes had a high response rate to TRK inhibitors, NTRK fusion gene testing is recommended for patients with known cancer types in which NTRK fusion genes are detected at a high frequency (including those detected at a relatively high frequency in Table 3).